Clin2
NCT06840704Possibly a fitRecruiting

Can immunonutrition reduce esophagitis during lung cancer radiation?

Non Small Cell Lung CancerSmall Cell Lung Cancer

Part of Cancer, Digestive system, Lungs & breathing clinical trials.

This trial tests if a special nutritional supplement (immunonutrition) can lower the risk of severe throat and chest irritation (esophagitis) caused by radiation therapy for lung cancer. You may qualify if you are about to start chest radiation and can eat normally.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
121 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with lung cancer (any type) and need radiation therapy to your chest area.
  • You are at least 18 years old.
  • You can still eat food by mouth without help.
  • You are in generally good health (able to do daily activities without help).
  • You have not had radiation to your chest before.
  • You do not have other cancers or active esophagus problems (like reflux or invasion).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07076914Not yet recruiting· Phase 2
Acid-reducing medication for esophagus protection during lung radiation

This trial tests whether taking a daily acid-reducing medication (a PPI, like omeprazole) during radiation for lung cancer can protect your food pipe (esophagus) from irritation. The goal is to reduce discomfort like pain or difficulty swallowing caused by radiation.

London, Ontario
NCT06342167Recruiting· Phase 2
Immunotherapy and radiation with nutrition support for esophageal cancer

This trial combines an immunotherapy drug (a PD-1 inhibitor) with radiation therapy and special nutrition drinks to treat esophageal cancer that cannot be removed with surgery. The goal is to see if this combination is safe and effective in helping patients live longer and feel better.

Beijing, Beijing Municipality
NCT05384873Recruiting
Immunonutrition to improve immunotherapy in metastatic lung cancer

This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.

Pavia
NCT07514754Recruiting
Immunonutrition support during cancer treatment

This study tests whether special nutritional support (called immunonutrition) helps patients with head and neck, lung, or rectal cancer who are receiving chemotherapy, radiation, or immunotherapy. The goal is to see if it improves how well treatment works and how you feel during and after cancer care.

Candiolo, Torino (TO)
NCT07017218Not yet recruiting
Nutrition and immunity support during radiation for head and neck cancer

This trial tests whether a special nutritional supplement can help maintain your nutrition and immune system during radiation therapy for head and neck cancer. It aims to reduce side effects and improve your overall health during treatment.

NCT06923020Enrolling by invitation
Nutrition and immunotherapy for advanced stomach and esophagus cancer

This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.

Zhengzhou, Henan

Hear when a new Non Small Cell Lung Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.